Showing results (1411-1420 of 1,626) with videos related to

Sort By:
Pageof 163
Southern African Journal of HIV Medicine|October 17, 2019
Evaluation of a health system intervention to improve virological management in an antiretroviral programme at a municipal clinic in central DurbanChristie M Cloete, Jane Hampton, Terusha Chetty, et al.
Mobius|September 7, 1984
Designing education interventions to improve physician performance in office practiceP A Jennett, O E Laxdal, R C Hayton, et al.
Plos One|September 21, 2011
Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control itSebastian Virreira Winter, Wendy Niedelman, Kirk D Jensen, et al.
Health and Quality of Life Outcomes|August 12, 2015
Adverse childhood experiences and health-related quality of life in adulthood: revelations from a community needs assessmentAbraham A Salinas-Miranda, Jason L Salemi, Lindsey M King, et al.
AIDS (London, England)|April 20, 2004
The impact of HIV on mortality rates in the complete UK haemophilia populationSarah C Darby, Sau Wan Kan, Rosemary J D Spooner, et al.
Parasite Immunology|May 1, 1984
A histocompatibility barrier to immunization against East Coast fever using Theileria parva-infected lymphoblastoid cell linesT T Dolan, A J Teale, D A Stagg, et al.
The American Journal of Tropical Medicine and Hygiene|May 12, 2006
Mefloquine use and hospitalizations among US service members, 2002-2004Timothy S Wells, Tyler C Smith, Besa Smith, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
The design and synthesis of novel orally active inhibitors of AP-1 and NF-kappaB mediated transcriptional activation. SAR of in vitro and in vivo studiesMoorthy S S Palanki, Paul E Erdman, Minghuan Ren, et al.
Database : the Journal of Biological Databases and Curation|February 17, 2010
Gramene QTL database: development, content and applicationsJunjian Ni, Anuradha Pujar, Ken Youens-Clark, et al.
Journal of Medicinal Chemistry|March 29, 1996
The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analoguesP A Procopiou, B Cox, B E Kirk, et al.
Pageof 163